PharmaResearch Co., Ltd. (KOSDAQ:214450)

South Korea flag South Korea · Delayed Price · Currency is KRW
632,000
-23,000 (-3.51%)
Sep 3, 2025, 11:40 AM KST
-3.51%
Market Cap6.81T
Revenue (ttm)449.81B
Net Income (ttm)126.99B
Shares Out10.39M
EPS (ttm)12,241.25
PE Ratio53.51
Forward PE32.44
Dividend1,100.00 (0.17%)
Ex-Dividend DateDec 27, 2024
Volume44,648
Average Volume91,144
Open650,000
Previous Close655,000
Day's Range628,000 - 654,000
52-Week Range165,300 - 713,000
Beta0.60
RSI53.21
Earnings DateAug 12, 2025

About PharmaResearch

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults thro... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 409
Stock Exchange KOSDAQ
Ticker Symbol 214450
Full Company Profile

Financial Performance

In 2024, PharmaResearch's revenue was 350.12 billion, an increase of 34.14% compared to the previous year's 261.01 billion. Earnings were 92.04 billion, an increase of 20.24%.

Financial Statements

News

There is no news available yet.